Skip to content

PERCEPTIVE ADVISORS LLC

Follow

13F filer, CIK 1224962, NEW YORK, NY

PERCEPTIVE ADVISORS LLC reported $5,740,273,309 across 108 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 52.05% of the portfolio.

Accepted , ingested 13F-HR 0001012975-26-001063

Period
2026-09-30
Reported value
$5.74B
Holdings
108
Top 10 weight
52.05%
New
26
Sold out
27

Part of the filer group PERCEPTIVE ADVISORS LLC

How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • TRIB TRINITY BIOTECH INVT LTD: 13D/A 54,148,590 shares, 9.99% of the class, 13D/A filed 2026-11-10, 0001193125-26-455946Timeline
    Accepted , ingested
  • IRLA QUINCE THERAPEUTICS INC: 13G 912,853 shares, 8.4% of the class, 13G filed 2026-10-14, 0001193125-26-421651Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
FRNMnew+12,606,053$199M
AMLXadded+2,238,853$65.2M
WATnew+135,000$59.3M
IRDnew+9,000,000$43.6M
LKFTnew+1,242,404$36.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NUVLexited-1,580,505-$195M
APGEexited-1,308,113-$174M
SYREreduced-1,038,553-$92.5M
ROIVreduced-1,574,500-$57.6M
BIIBreduced-248,143-$56.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001012975-26-001063, largest first. % of portfolio is the value over $5,340,357,540, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,329,735 shares; 2025Q1: 980,894 shares; 2025Q2: 752,921 shares; 2025Q3: 1,564,554 shares; 2025Q4: 1,995,986 shares; 2026Q1: 2,035,986 shares; 2026Q2: 2,035,986 shares; 2026Q3: 2,024,781 shares 2,024,781$590M11.04%-11,205Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,774,348 shares; 2025Q1: 7,874,348 shares; 2025Q2: 7,902,365 shares; 2025Q3: 8,952,365 shares; 2025Q4: 8,284,882 shares; 2026Q1: 8,284,882 shares; 2026Q2: 8,334,882 shares; 2026Q3: 10,573,735 shares 10,573,735$308M5.76%+2,238,853Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,574,723 shares; 2025Q1: 2,313,272 shares; 2025Q2: 1,529,445 shares; 2025Q3: 1,229,445 shares; 2025Q4: 3,069,225 shares; 2026Q1: 3,783,225 shares; 2026Q2: 4,319,496 shares; 2026Q3: 3,280,943 shares 3,280,943$292M5.47%-1,038,553Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,362,279 shares; 2025Q1: 2,362,279 shares; 2025Q2: 1,633,208 shares; 2025Q3: 2,956,319 shares; 2025Q4: 3,160,200 shares; 2026Q1: 3,127,200 shares; 2026Q2: 3,197,200 shares; 2026Q3: 3,179,794 shares 3,179,794$253M4.73%-17,406Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,680,473 shares; 2025Q1: 2,548,445 shares; 2025Q2: 2,418,299 shares; 2025Q3: 2,438,969 shares; 2025Q4: 2,546,391 shares; 2026Q1: 2,373,795 shares; 2026Q2: 2,586,295 shares; 2026Q3: 2,532,556 shares 2,532,556$241M4.52%-53,739Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,331,465 shares; 2025Q3: 7,368,461 shares; 2025Q4: 7,985,461 shares; 2026Q1: 8,285,461 shares; 2026Q2: 8,085,461 shares; 2026Q3: 6,510,961 shares 6,510,961$238M4.46%-1,574,500Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,903,245 shares; 2026Q1: 9,751,141 shares; 2026Q2: 14,106,187 shares; 2026Q3: 12,730,336 shares 12,730,336$230M4.3%-1,375,851Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,163,721 shares; 2026Q3: 971,521 shares 971,521$221M4.14%-192,200Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 834,252 shares; 2025Q3: 3,794,615 shares; 2025Q4: 4,278,180 shares; 2026Q1: 4,142,551 shares; 2026Q2: 3,752,574 shares; 2026Q3: 3,542,913 shares 3,542,913$209M3.91%-209,661Timeline
FRNMFREENOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 12,606,053 shares 12,606,053$199M3.72%newTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,685,537 shares; 2025Q1: 6,547,328 shares; 2025Q2: 4,639,949 shares; 2025Q3: 3,795,894 shares; 2025Q4: 4,457,974 shares; 2026Q1: 4,423,974 shares; 2026Q2: 4,373,974 shares; 2026Q3: 4,138,282 shares 4,138,282$168M3.15%-235,692Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,064,026 shares; 2025Q1: 1,064,026 shares; 2025Q2: 977,892 shares; 2025Q3: 1,327,707 shares; 2025Q4: 1,452,707 shares; 2026Q1: 1,442,707 shares; 2026Q2: 1,297,763 shares; 2026Q3: 1,292,463 shares 1,292,463$129M2.42%-5,300Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 330,614 shares; 2025Q1: 297,553 shares; 2025Q2: 1,096,985 shares; 2025Q3: 1,416,149 shares; 2025Q4: 3,555,877 shares; 2026Q1: 3,710,877 shares; 2026Q2: 4,320,422 shares; 2026Q3: 5,371,629 shares 5,371,629$127M2.38%+1,051,207Timeline
KARDKARDIGAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 8,200,662 shares; 2026Q3: 8,200,662 shares 8,200,662$121M2.27%0Timeline
MGTXMEIRAGTX HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,581,103 shares; 2025Q1: 12,581,103 shares; 2025Q2: 12,626,103 shares; 2025Q3: 12,626,103 shares; 2025Q4: 10,326,103 shares; 2026Q1: 10,326,103 shares; 2026Q2: 10,786,658 shares; 2026Q3: 10,786,658 shares 10,786,658$119M2.22%0Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,271,662 shares; 2025Q1: 1,091,271 shares; 2025Q2: 1,074,448 shares; 2025Q3: 1,030,134 shares; 2025Q4: 1,350,425 shares; 2026Q1: 1,230,879 shares; 2026Q2: 981,879 shares; 2026Q3: 836,579 shares 836,579$118M2.21%-145,300Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,383,456 shares; 2025Q1: 9,383,456 shares; 2025Q2: 9,383,456 shares; 2025Q3: 9,383,456 shares; 2025Q4: 10,383,456 shares; 2026Q1: 10,383,456 shares; 2026Q2: 10,383,456 shares; 2026Q3: 11,246,516 shares 11,246,516$98.7M1.85%+863,060Timeline
ZYMEZYMEWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,130,020 shares; 2025Q1: 1,864,672 shares; 2025Q2: 1,275,274 shares; 2025Q3: 2,090,663 shares; 2025Q4: 3,261,850 shares; 2026Q1: 3,510,078 shares; 2026Q2: 4,182,953 shares; 2026Q3: 3,545,501 shares 3,545,501$93.9M1.76%-637,452Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 845,567 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,268,021 shares; 2025Q4: 1,476,501 shares; 2026Q1: 1,395,501 shares; 2026Q2: 1,345,063 shares; 2026Q3: 1,072,363 shares 1,072,363$89.3M1.67%-272,700Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 258,600 shares; 2026Q2: 527,600 shares; 2026Q3: 433,100 shares 433,100$88.9M1.66%-94,500Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,906,646 shares; 2025Q1: 11,906,646 shares; 2025Q2: 11,906,646 shares; 2025Q3: 11,833,539 shares; 2025Q4: 11,833,539 shares; 2026Q1: 11,906,646 shares; 2026Q2: 11,906,646 shares; 2026Q3: 11,906,646 shares 11,906,646$86.1M1.61%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,162,529 shares; 2026Q1: 7,434,033 shares; 2026Q2: 10,308,888 shares; 2026Q3: 10,301,888 shares 10,301,888$85.8M1.61%-7,000Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,675,296 shares; 2026Q3: 2,675,296 shares 2,675,296$76.2M1.43%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 513,035 shares; 2026Q1: 808,153 shares; 2026Q2: 3,377,000 shares; 2026Q3: 2,693,000 shares 2,693,000$67.2M1.26%-684,000Timeline
WATWATERS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 135,000 shares 135,000$59.3M1.11%newTimeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 129,801 shares; 2025Q2: 166,000 shares; 2025Q3: 270,428 shares; 2025Q4: 315,541 shares; 2026Q1: 280,541 shares; 2026Q2: 248,212 shares; 2026Q3: 272,456 shares 272,456$52.4M0.98%+24,244Timeline
AORTARTIVION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,793,703 shares; 2025Q1: 2,793,703 shares; 2025Q2: 2,793,703 shares; 2025Q3: 2,020,000 shares; 2025Q4: 1,722,290 shares; 2026Q1: 1,637,290 shares; 2026Q2: 1,737,290 shares; 2026Q3: 2,112,290 shares 2,112,290$48.2M0.9%+375,000Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 155,366 shares; 2025Q4: 1,784,393 shares; 2026Q1: 2,009,893 shares; 2026Q2: 1,609,893 shares; 2026Q3: 1,760,950 shares 1,760,950$45M0.84%+151,057Timeline
IRDOPUS GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 4,325,000 shares; 2025Q2: 4,325,000 shares; 2025Q3: 4,325,000 shares; 2025Q4: 4,325,000 shares; 2026Q1: 1,835,842 shares; 2026Q2: not reported; 2026Q3: 9,000,000 shares 9,000,000$43.6M0.82%newTimeline
LKFTLAKEFRONT BIOTHERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,242,404 shares 1,242,404$36.8M0.69%newTimeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 345,225 shares 345,225$34.1M0.64%newTimeline
BLSMBLOSSOMHILL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,812,193 shares 1,812,193$33.8M0.63%newTimeline
OBIOORCHESTRA BIOMED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,592,556 shares; 2025Q1: 4,592,556 shares; 2025Q2: 4,592,556 shares; 2025Q3: 5,292,556 shares; 2025Q4: 5,127,256 shares; 2026Q1: 5,037,906 shares; 2026Q2: 5,037,906 shares; 2026Q3: 5,037,606 shares 5,037,606$31.3M0.59%-300Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,438,595 shares; 2025Q3: 1,438,595 shares; 2025Q4: 692,441 shares; 2026Q1: 2,292,441 shares; 2026Q2: 2,667,441 shares; 2026Q3: 2,510,441 shares 2,510,441$28.9M0.54%-157,000Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,140,000 shares; 2025Q1: 2,140,000 shares; 2025Q2: 1,705,130 shares; 2025Q3: 1,705,130 shares; 2025Q4: 1,675,476 shares; 2026Q1: 3,425,476 shares; 2026Q2: 3,425,476 shares; 2026Q3: 3,425,476 shares 3,425,476$26.6M0.5%0Timeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,793,190 shares; 2026Q3: 1,660,502 shares 1,660,502$26.6M0.5%-132,688Timeline
MMEDMINIMED GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,320,000 shares 1,320,000$25.7M0.48%newTimeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 6,993,646 shares; 2025Q3: 9,680,185 shares; 2025Q4: 9,680,185 shares; 2026Q1: 10,098,824 shares; 2026Q2: 10,439,185 shares; 2026Q3: 9,268,061 shares 9,268,061$25.2M0.47%-1,171,124Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 311,551 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 403,923 shares; 2025Q4: 673,923 shares; 2026Q1: 673,923 shares; 2026Q2: 773,342 shares; 2026Q3: 724,342 shares 724,342$24.3M0.46%-49,000Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 750,000 shares; 2025Q1: not reported; 2025Q2: 541,450 shares; 2025Q3: 541,450 shares; 2025Q4: 433,160 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 567,479 shares 567,479$22.2M0.42%newTimeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 6,314,452 shares; 2026Q1: 6,737,648 shares; 2026Q2: 7,933,491 shares; 2026Q3: 7,350,491 shares 7,350,491$21.3M0.4%-583,000Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 462,506 shares 462,506$21.2M0.4%newTimeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 803,210 shares; 2026Q1: 6,431,743 shares; 2026Q2: 6,627,501 shares; 2026Q3: 6,627,501 shares 6,627,501$21M0.39%0Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 543,277 shares; 2025Q1: 2,313,403 shares; 2025Q2: 2,247,390 shares; 2025Q3: 540,444 shares; 2025Q4: 3,478,944 shares; 2026Q1: 4,668,839 shares; 2026Q2: 2,689,235 shares; 2026Q3: 1,265,362 shares 1,265,362$20.4M0.38%-1,423,873Timeline
EOLSEVOLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,145,846 shares; 2025Q1: 4,129,142 shares; 2025Q2: 2,474,843 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,286,862 shares; 2026Q2: 2,459,285 shares; 2026Q3: 2,459,285 shares 2,459,285$19.7M0.37%0Timeline
YARWYARROW BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 813,098 shares 813,098$18.3M0.34%newTimeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,139,199 shares; 2025Q1: 2,844,072 shares; 2025Q2: 2,137,890 shares; 2025Q3: 1,587,890 shares; 2025Q4: 1,994,890 shares; 2026Q1: 1,597,383 shares; 2026Q2: 1,357,383 shares; 2026Q3: 519,345 shares 519,345$17.5M0.33%-838,038Timeline
SCTXSCRIBE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 920,341 shares 920,341$16.9M0.32%newTimeline
NAUTNAUTILUS BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,594,211 shares; 2025Q1: 12,594,211 shares; 2025Q2: 12,594,211 shares; 2025Q3: 12,594,211 shares; 2025Q4: 12,594,211 shares; 2026Q1: 12,594,211 shares; 2026Q2: 11,634,211 shares; 2026Q3: 11,564,744 shares 11,564,744$16.4M0.31%-69,4672026-10-05, 13D/A: 4,944,512 shares, 3.9% of the class, 13D/A filed 2026-11-03 Timeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 715,307 shares; 2026Q2: 1,304,846 shares; 2026Q3: 970,846 shares 970,846$15.6M0.29%-334,000Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 229,393 shares; 2026Q2: 503,985 shares; 2026Q3: 439,685 shares 439,685$14.1M0.26%-64,300Timeline
GRALGRAIL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 237,342 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 96,911 shares 96,911$13.6M0.25%newTimeline
DBVTDBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 964,391 shares; 2026Q2: 1,653,350 shares; 2026Q3: 1,136,534 shares 1,136,534$13.4M0.25%-516,816Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 200,000 shares; 2026Q1: not reported; 2026Q2: 130,000 shares; 2026Q3: 60,000 shares 60,000$13.3M0.25%-70,000Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 65,153 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 123,000 shares; 2025Q4: 108,000 shares; 2026Q1: 105,026 shares; 2026Q2: 223,766 shares; 2026Q3: 113,766 shares 113,766$12.9M0.24%-110,000Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 160,000 shares; 2026Q1: 300,000 shares; 2026Q2: 41,327 shares; 2026Q3: 70,000 shares 70,000$12.5M0.23%+28,673Timeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 21,785,166 shares; 2026Q1: 20,859,303 shares; 2026Q2: 18,490,636 shares; 2026Q3: 13,762,637 shares 13,762,637$12M0.22%-4,727,999Timeline
ADPTADAPTIVE BIOTECHNOLOGIES CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 930,972 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 152,500 shares; 2026Q2: 1,217,325 shares; 2026Q3: 412,325 shares 412,325$11.9M0.22%-805,000Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 97,000 shares 97,000$11.8M0.22%newTimeline
AXGNAXOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 784,140 shares; 2026Q1: 697,312 shares; 2026Q2: 247,312 shares; 2026Q3: 280,000 shares 280,000$11.7M0.22%+32,688Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 12,050,000 shares; 2026Q1: 8,928,149 shares; 2026Q2: 8,425,065 shares; 2026Q3: 8,425,065 shares 8,425,065$11.4M0.21%0Timeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 453,686 shares; 2025Q3: 453,686 shares; 2025Q4: 453,686 shares; 2026Q1: 206,942 shares; 2026Q2: 206,942 shares; 2026Q3: 706,942 shares 706,942$10.3M0.19%+500,000Timeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,593,608 shares; 2025Q2: 1,593,608 shares; 2025Q3: 277,944 shares; 2025Q4: 602,944 shares; 2026Q1: 842,944 shares; 2026Q2: 832,944 shares; 2026Q3: 538,159 shares 538,159$10.2M0.19%-294,785Timeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000$10.1M0.19%0Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,431,372 shares 3,431,372$9.99M0.19%newTimeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 259,545 shares; 2026Q1: not reported; 2026Q2: 115,391 shares; 2026Q3: 115,391 shares 115,391$9.86M0.18%0Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 168,000 shares; 2026Q3: 402,773 shares 402,773$9.73M0.18%+234,773Timeline
XERSXERIS BIOPHARMA HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 467,013 shares; 2026Q3: 933,671 shares 933,671$8.93M0.17%+466,658Timeline
RACDRESEARCH ALLIANCE CORP IVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 700,000 shares 700,000$8.29M0.16%newTimeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 850,000 shares 850,000$8.05M0.15%newTimeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,486,508 shares; 2025Q1: 659,662 shares; 2025Q2: 447,507 shares; 2025Q3: 1,462,400 shares; 2025Q4: 3,042,703 shares; 2026Q1: 1,170,829 shares; 2026Q2: 581,980 shares; 2026Q3: 381,452 shares 381,452$7.85M0.15%-200,528Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 388,608 shares; 2025Q4: 458,343 shares; 2026Q1: 328,884 shares; 2026Q2: 74,000 shares; 2026Q3: 74,000 shares 74,000$7.33M0.14%0Timeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,822,169 shares; 2026Q3: 3,482,169 shares 3,482,169$6.96M0.13%-1,340,000Timeline
BLLNBILLIONTOONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 72,812 shares; 2026Q1: 91,812 shares; 2026Q2: 86,812 shares; 2026Q3: 65,209 shares 65,209$6.94M0.13%-21,603Timeline
AGMBAGOMAB THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 600,000 shares; 2026Q2: 600,000 shares; 2026Q3: 600,000 shares 600,000$6.66M0.12%0Timeline
LONALEONABIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 540,296 shares; 2025Q4: 1,859,322 shares; 2026Q1: 1,859,322 shares; 2026Q2: 1,859,322 shares; 2026Q3: 1,859,322 shares 1,859,322$6.64M0.12%02026-10-26, 13D/A: 1,889,403 shares, 19.99% of the class, 13D/A filed 2026-10-26 Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 124,000 shares; 2026Q1: not reported; 2026Q2: 276,173 shares; 2026Q3: 28,030 shares 28,030$6.33M0.12%-248,143Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 282,524 shares 282,524$6.01M0.11%newTimeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$5.98M0.11%newTimeline
NVCTNUVECTIS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,000,000 shares; 2026Q3: 240,000 shares 240,000$5.07M0.09%-760,000Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 165,713 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 575,000 shares 575,000$4.97M0.09%newTimeline
OCSOCULIS HOLDING AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 493,827 shares; 2026Q1: 493,827 shares; 2026Q2: 808,827 shares; 2026Q3: 440,827 shares 440,827$4.12M0.08%-368,000Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 116,806 shares; 2026Q3: 10,000 shares 10,000$3.67M0.07%-106,806Timeline
MOBIMOBIA MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 523,654 shares; 2026Q3: 343,654 shares 343,654$3.25M0.06%-180,000Timeline
RVMDWREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 250,000 shares; 2025Q1: 250,000 shares; 2025Q2: 250,000 shares; 2025Q3: 250,000 shares; 2025Q4: 250,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000$2.86M0.05%0Timeline
OMOUTSET MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 833,333 shares; 2025Q2: 833,333 shares; 2025Q3: 833,333 shares; 2025Q4: 833,333 shares; 2026Q1: 833,333 shares; 2026Q2: 833,333 shares; 2026Q3: 833,333 shares 833,333$2.5M0.05%0Timeline
CBLLCERIBELL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 180,546 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 98,779 shares 98,779$2.41M0.05%newTimeline
EDSAEDESA BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 563,239 shares; 2026Q2: 563,239 shares; 2026Q3: 563,239 shares 563,239$2.37M0.04%0Timeline
BRVEBRAVEHEART BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 115,000 shares 115,000$2.32M0.04%newTimeline
OTLKOUTLOOK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,139,216 shares; 2026Q3: 3,139,216 shares 3,139,216$1.8M0.03%0Timeline
ADGMADAGIO MED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,812,419 shares; 2025Q1: 9,812,419 shares; 2025Q2: 9,876,576 shares; 2025Q3: 9,876,576 shares; 2025Q4: 9,876,576 shares; 2026Q1: 9,876,576 shares; 2026Q2: 9,876,586 shares; 2026Q3: 9,876,586 shares 9,876,586$1.51M0.03%0Timeline
ADMAADMA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 890,280 shares; 2025Q1: 1,373,233 shares; 2025Q2: 1,303,468 shares; 2025Q3: 1,153,468 shares; 2025Q4: 883,468 shares; 2026Q1: 467,233 shares; 2026Q2: 113,765 shares; 2026Q3: 113,765 shares 113,765$1.14M0.02%0Timeline
KPRXKIORA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 438,471 shares; 2026Q3: 438,471 shares 438,471$1.12M0.02%0Timeline
MDLNMEDLINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 28,000 shares; 2026Q1: 28,000 shares; 2026Q2: 28,000 shares; 2026Q3: 28,000 shares 28,000$972K0.02%0Timeline
XGNEXAGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 114,893 shares; 2026Q2: 114,893 shares; 2026Q3: 114,893 shares 114,893$934K0.02%0Timeline
CNTBCONNECT BIOPHARMA HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 792,696 shares; 2026Q1: 792,696 shares; 2026Q2: 792,696 shares; 2026Q3: 792,696 shares 792,696$872K0.02%0Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 67,674 shares 67,674$669K0.01%newTimeline
IBITISHARES BITCOIN TRUST ETFQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 12,000 shares 12,000$568K0.01%newTimeline
ENSCENSYSCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 86,666 shares; 2025Q1: 86,666 shares; 2025Q2: 86,666 shares; 2025Q3: 86,666 shares; 2025Q4: 86,666 shares; 2026Q1: 86,666 shares; 2026Q2: 86,666 shares; 2026Q3: 86,666 shares 86,666$36K<0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
MRNAMODERNA INC COMput1,400,000$270M+400,000
SLSSELLAS LIFE SCIENCES GROUP I COM NEWcall3,000,000$36.9Mnew
XBISPDR SERIES TRUST S&P BIOTECHput200,000$31.5M-100,000
SLSSELLAS LIFE SCIENCES GROUP I COM NEWput2,500,000$30.8M+1,000,000
NAMSNEWAMSTERDAM PHARMA COMPANY COMMON STOCKput600,000$14.6M+100,000
EYPTEYEPOINT INC Stockput3,500,000$11.4M+1,500,000
BHVNBIOHAVEN LTD COMput200,000$2.67Mnew
EYPTEYEPOINT INC Stockcall724,700$2.37Mnew

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
CELCUITY INCCELCUITY INC NOTE 2.750% 8/0principal6,500,000$11.7M0

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
NUVLNUVALENT INC1,580,505$195Mshares
APGEAPOGEE THERAPEUTICS INC1,308,113$174Mshares
IONSIONIS PHARMACEUTICALS INC566,000$44.9Mshares
JAZZJAZZ PHARMACEUTICALS PLC170,000$41Mshares
SIONSIONNA THERAPEUTICS INC905,000$39.8Mshares
CORTCORCEPT THERAPEUTICS INC398,385$34.6Mshares
DMRADAMORA THERAPEUTICS INC1,223,000$31.8Mshares
CRLCHARLES RIV LABS INTL INC140,000$31.8Mshares
AXSMAXSOME THERAPEUTICS INC.118,450$29Mshares
TENXTENAX THERAPEUTICS INC1,700,000$24.7Mshares
CAPRCAPRICOR THERAPEUTICS INC1,000,000$24.1Mcall
ISRGINTUITIVE SURGICAL INC51,884$20.6Mshares
CTNMCONTINEUM THERAPEUTICS INC1,255,592$20.6Mshares
OMDAOMADA HEALTH INC786,330$17.3Mshares
CAPRCAPRICOR THERAPEUTICS INC500,000$12Mput
OSCROSCAR HEALTH INC400,000$11.4Mshares
BSXBOSTON SCIENTIFIC CORP250,000$10.7Mshares
NTRANATERA INC34,689$9.42Mshares
RACCRESEARCH ALLIANCE CORP III750,000$8.03Mshares
CGEMCULLINAN THERAPEUTICS INC426,478$7.77Mshares
PHATPHATHOM PHARMACEUTICALS INC532,000$5.77Mshares
COGTCOGENT BIOSCIENCES INC121,082$4.69Mshares
AVTXAVALO THERAPEUTICS INC219,813$4.06Mshares
TWSTTWIST BIOSCIENCE CORP36,812$3.79Mshares
BDSXBIODESIX INC108,694$2.45Mshares
CPIXCUMBERLAND PHARMACEUTICALS I96,982$628Kshares
SRZNWSURROZEN INC166,666$2.75Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001012975-26-001063 base2026-11-16